Hepatitis E: The Endemic Perspective
|
|
- Sherman Weaver
- 5 years ago
- Views:
Transcription
1 REVIEW Hepatitis E: The Endemic Perspective Rakesh Aggarwal, M.D., D.M. Hepatitis E is the term used for disease caused by infection with hepatitis E virus (HEV). It is endemic in several parts of Africa and Asia, including the Indian subcontinent (Fig. 1), where it is often the most common cause of acute hepatitis. This review covers the key features of this disease from the perspective of a physician-hepatologist working in an area where the disease is endemic. Epidemiology of Hepatitis E in Endemic Areas In endemic regions, hepatitis E may present either as part of an outbreak or as isolated (sporadic) cases. The clinical characteristics of patients with epidemic hepatitis E and patients with sporadic hepatitis E are similar. Hepatitis E epidemics vary from small, unimodal outbreaks lasting a few weeks to large, multipeak epidemics lasting many months with several thousand cases. 1,2 The outbreaks are usually related to the contamination of drinking water supplies with human fecal matter that contains HEV. Several natural and manmade circumstances facilitate water contamination and hence the occurrence of such outbreaks. These include heavy rainfall and flooding, diminution of water flow in rivers during hot summers, disposal of sewage into rivers, leaky water pipes with intermittent water supplies passing through sewage-contaminated soil, and large-scale human displacements due to wars and internal conflicts. Occasional small, food-borne outbreaks have also been reported. In most outbreaks, person-to-person transmission has been insignificant. The outbreaks in these areas have invariably been due to HEV genotype 1 or 2. The zoonotic transmission of genotype 3 or 4 HEV from pigs or other animal reservoirs, the predominant mode of spread in nonendemic areas, has not been reported in endemic areas, and is either nonexistent or infrequent. Clinical Manifestations In endemic areas, hepatitis E, epidemic and sporadic, occurs most frequently in the age group of 10 to 40 years. Men tend to be affected somewhat more often; this may be related to greater exposure to contaminated water. The clinical outcomes of HEV infection vary widely 3,4 (Table 1). The most commonly observed illness is acute icteric hepatitis of variable severity. The illness often has two distinct phases. The initial pre-icteric phase consists of fever, malaise, anorexia, nausea, vomiting, bowel alterations, and abdominal pain lasting for a few days. This is followed by an icteric phase, which is characterized by dark urine and jaundice, lasts for a few weeks, and is usually followed by spontaneous resolution. Physical examination reveals jaundice, hepatomegaly, and sometimes a soft, palpable spleen. This illness in individual patients is usually indistinguishable from illness caused by other hepatotropic viruses (e.g., hepatitis A virus and hepatitis B virus) except for epidemiological features, such as occurrence as outbreaks, association with water contamination, young age, and a predilection to occur in pregnant women. Some patients experience a period of prolonged cholestatic symptoms with troublesome itching and jaundice persisting for several weeks; however, these usually resolve with time with no adverse outcome. A few patients develop severe liver injury, which manifests as fulminant liver failure (FHF) or subacute liver failure, either of which may be fatal. In contrast, many persons with HEV infection have mild liver injury with liver enzyme elevations but no icterus (anicteric hepatitis). A large proportion of persons with serological evidence of HEV infection have no past history of liver illness, and this suggests that asymptomatic infection is common. The overall mortality rate for those affected during an outbreak is usually low (<1/1000). Abbreviations: FHF, fulminant liver failure; HEV, hepatitis E virus; Ig, immunoglobulin From the Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India Potential conflict of interest: Nothing to report. There is additional supporting information for this article. View this article online at wileyonlinelibrary.com VC 2013 by the American Association for the Study of Liver Diseases doi: /cld Clinical Liver Disease, Vol 2, No 6, December 2013 An Official Learning Resource of AASLD
2 FIGURE 1 Geographical areas where hepatitis E is endemic (as evidenced by the occurrence of outbreaks or a large proportion of sporadic acute hepatitis cases being due to hepatitis E). Reprinted with permission from Journal of Gastroenterology and Hepatology. 1 Copyright 2009, John Wiley & Sons, Inc. TABLE 1 Clinical Manifestations of Liver Involvement in Hepatitis E Presentation Acute icteric hepatitis Fulminant hepatitis Anicteric hepatitis Unapparent infection Acute-on-chronic liver disease Details Illness resembling other forms of acute viral hepatitis Leads to acute liver failure (more common in pregnant women) Biochemical abnormalities but no jaundice Asymptomatic but leads to anti-hev antibodies With infection in persons with preexisting liver disease Importantly, no chronic sequelae of HEV infections or persistent HEV infections have been identified in endemic areas to date. Hepatitis E in Pregnant Women A characteristic feature of hepatitis E in endemic areas is its association with a high disease attack rate, a high rate of FHF development, and a high mortality rate in pregnant women. The mechanism of this predilection remains unclear. In an outbreak in Kashmir, India, 8.8%, 19.4%, and 18.6% of pregnant women in the first, second, and third trimesters, respectively, had symptomatic disease, whereas only 2.1% of nonpregnant women and 2.8% of men did so. 5 Furthermore, 22% of the affected pregnant cases developed FHF, whereas none of the affected nonpregnant women and only 3% of the affected men did so. Similar findings have been reported for other outbreaks 6-9 and for cases with sporadic endemic hepatitis E. 10 This predilection results in a much higher overall mortality rate for pregnant women versus nonpregnant women and men during hepatitis E outbreaks (Fig. 2). Some infants born to mothers with hepatitis E acquire an HEV infection through the transplacental route. Such infants are often born premature, may manifest hypothermia, hypoglycemia, or icteric or anicteric hepatitis, and have a mortality rate approaching 50%. 11 Acute Hepatitis E Superimposed on Chronic Liver Disease When HEV infects a person with preexisting liver disease, the manifestations may be somewhat different. Because of a lower functional hepatic reserve, acute liver injury due to hepatitis E may be expected to more often lead to symptomatic disease or liver failure (Fig. 3). These patients often present with a clinical syndrome of acute-on-chronic liver failure. In one study, 12 evidence of a recent HEV infection was found in nearly one-half of Indian patients with chronic liver disease and recent decompensation; in many of these patients, chronic liver disease had been asymptomatic until the infection with HEV. The underlying chronic liver disease may have been due to another hepatitis virus or a nonviral cause. Illness in these patients initially resembles typical acute viral hepatitis. However, within a few days to weeks, ascites, encephalopathy, or both appear, suggesting decompensated liver disease. Acute hepatitis E superimposed on chronic liver disease must be distinguished from severe acute hepatitis E. This may require additional investigation, including imaging or endoscopic findings characteristic of chronic liver damage or portal hypertension. The outcome of such 241 Clinical Liver Disease, Vol 2, No 6, December 2013 An Official Learning Resource of AASLD
3 patients is poorer than those of otherwise healthy persons with hepatitis E. 13 Diagnosis In endemic areas, patients suspected to have hepatitis E undergo biochemical liver function tests to confirm the diagnosis of acute hepatitis (conjugated hyperbilirubinemia, markedly elevated alanine and aspartate aminotransferase levels, and sometimes mildly elevated alkaline phosphatase levels) and serological tests to look for evidence of a recent HEV infection and to exclude an infection with another hepatitis virus. Some patients may need an ultrasound examination to exclude biliary obstruction or liver abscess. The most commonly used method to detect a recent HEV infection is one of the several available enzyme immunoassays for immunoglobulin M (IgM) anti-hev antibodies, which appear almost simultaneously with the onset of symptoms and persist for a few months. These assays vary widely in their performance characteristics, 14 but they generally appear to perform better in endemic areas than in nonendemic areas. None of the assays are approved for use in the United States. In patients with acute hepatitis E in endemic areas, IgM anti-hev is often accompanied by a high level of IgG anti- HEV, which may out-compete the IgM antibodies in conventional immunoassays. Hence, assays with an IgM capture format have been devised, and these appear to perform better. 15 The detection of HEV RNA is more specific for HEV infections; however, HEV RNA disappears early in the disease, and the results may be negative by the time the patient presents to a physician. Also, facilities for HEV RNA assays in disease-endemic areas are limited. Anti-HEV IgG has no role in the diagnosis of hepatitis E in endemic areas. Treatment In endemic areas, hepatitis E is generally self-limiting, so only supportive measures for the relief of fever, body aches, vomiting, and so forth are required; no specific treatment is deemed necessary. Whether specific treatment can benefit patients with hepatitis E related FHF, including pregnant women, or patients with chronic liver disease and HEV superinfections remains unclear because no clinical trials have been performed. The results of successful antiviral therapy using interferon or ribavirin for chronic infections with HEV genotype 3 in FIGURE 2. FIGURE 2 (A) This schematic diagram presents the clinical outcomes of HEV infections in groups of pregnant women (represented by the dark blue rectangle) and nonpregnant women (represented by the light blue rectangle). (B) The pink circles represent the proportions of women in each group who acquire HEV infections; no data are available to show that these proportions differ between pregnant and nonpregnant women. (C) The yellow circles represent the number of women with HEV infections who develop icteric disease; this number is greater for pregnant women versus nonpregnant women. (D) The red circles represent the number of women who develop fulminant hepatic failure (FHF); this number is greater for pregnant women with symptomatic hepatitis E versus similar nonpregnant women. (E) The black pies in the innermost circles indicate the proportions of FHF patients who die. The proportions are similar for pregnant and nonpregnant women with HEV-induced FHF. However, because HEVinduced FHF is more common in pregnant women, the overall mortality rate due to HEV infection is higher among pregnant women versus nonpregnant women. Adapted with permission from Virus Research. 3 Copyright 2011, Elsevier B.V. 242 Clinical Liver Disease, Vol 2, No 6, December 2013 An Official Learning Resource of AASLD
4 FIGURE 3 (A) This schematic diagram shows the clinical outcomes of HEV infections in otherwise healthy persons and persons with preexisting chronic liver disease. The x axis represents time, and the y axis represents the relative liver function in arbitrary units. The pink and blue dotted lines represent arbitrary thresholds of liver function below which jaundice and signs of liver failure may be expected to develop. In a previously healthy person with an HEV infection, progressively increasing degrees of liver injury may be expected to lead to (B) anicteric hepatitis (curve a), (C) acute uncomplicated icteric hepatitis (curve b), or (D) FHF (curve c). (E) Persons with preexisting chronic liver disease (curve d) have suboptimal liver function to begin with. Thus, HEV infections in these patients would be expected to more often cause reduction of liver function below the thresholds for jaundice and liver failure. They are thus likely to develop jaundice or liver failure more often. Also, these symptoms can be expected (F) to last for a longer duration than they would in otherwise healthy persons or (G) or to result in death (dotted red line). Adapted with permission from Seminars in Liver Disease. 4 Copyright 2013, Georg Thieme Verlag KG. nonendemic areas cannot be easily extrapolated to patients in endemic areas for several reasons. These include (1) the short survival duration of patients with FHF (within which the drug must act for it to influence the outcome), (2) the differences in prevalent viral genotypes in endemic areas, (3) the risks associated with the use of these drugs during pregnancy (including the risk to the fetus), and (4) the possibility of the worsening of liver disease with interferon treatment (as is known with other forms of viral hepatitis). Prevention In endemic areas, hepatitis E can be prevented through steps that ensure safe drinking water supplies. Steps directed against zoonotic transmission from pig or deer meat are not of much importance in these areas. Two subunit vaccines that contain recombinant partial HEV capsid proteins have been shown to prevent hepatitis E. 16,17 However, several additional pieces of information are needed before these vaccines can be applied for the prevention of hepatitis E in endemic areas: better estimates of the disease burden in various populations, the efficacy and safety of the vaccines in high-risk groups (e.g., pregnant women and patients with liver disease), the efficacy of the vaccines when they are administered after exposure (for outbreak control), the duration of the protection offered, the need for and frequency of boosters, and the cost-benefit ratio of vaccine use. CORRESPONDENCE Rakesh Aggarwal, M.D., D.M., Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow , India. aggarwal.ra@gmail.com. 243 Clinical Liver Disease, Vol 2, No 6, December 2013 An Official Learning Resource of AASLD
5 References 1. Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 2009;24: Aggarwal R, Jameel S. Hepatitis E. Hepatology 2011;54: Aggarwal R. Clinical presentation of hepatitis E. Virus Res 2011;161: Aggarwal R. Hepatitis E: clinical presentation in disease-endemic areas and diagnosis. Semin Liver Dis 2013;33: Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70: Myint H, Soe MM, Khin T, Myint TM, Tin KM. A clinical and epidemiological study of an epidemic of non-a non-b hepatitis in Rangoon. Am J Trop Med Hyg 1985;34: Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Org 1992;70: Viswanathan R, Sidhu AS. Infectious hepatitis; clinical findings. Indian J Med Res 1957;45: Wahi PN, Arora MM. Epidemic hepatitis. N Engl J Med 1953;248: Khuroo MS, Duermeyer W, Zargar SA, Ahanger MA, Shah MA. Acute sporadic non-a, non-b hepatitis in India. Am J Epidemiol 1983;118: Khuroo MS, Kamili S, Khuroo MS. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat 2009;16: Kumar A, Aggarwal R, Naik SR, Saraswat V, Ghoshal UC, Naik S. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol 2004;23: Acharya SK, Sharma PK, Singh R, Mohanty SK, Madan K, Jha JK, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007;46: Drobeniuc J, Meng J, Reuter G, Greene-Montfort T, Khudyakova N, Dimitrova Z, et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010;51:e24-e Aggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 2013; 10: Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356: Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: Clinical Liver Disease, Vol 2, No 6, December 2013 An Official Learning Resource of AASLD
Hepatitis E in developing countries
Hepatitis E in developing countries Hepatitis E in developing countries Rakesh Aggarwal Department of Gastroenterology Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India Forms Epidemic
More informationHepatitis E FAQs for Health Professionals
Hepatitis E FAQs for Health Professionals Index of Questions ± Overview and Statistics What is Hepatitis E? How common is Hepatitis E in the United States? Where is Hepatitis E most common? Are there different
More informationHepatitis E Virus Update December 2014
655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2400 Fax 604.707.2516 www.bccdc.ca Hepatitis E Virus Update December 2014 What is hepatitis E Virus? Hepatitis E Virus (HEV) was first identified
More informationViral Hepatitis. Background
Viral Hepatitis Background Hepatitis or inflammation of the liver can be caused by infectious and noninfectious problems. Infectious etiologies include viruses, bacteria, fungi and parasites. Noninfectious
More informationHepatitis E Virus Infection. Disclosures
Hepatitis E Virus Infection Simona Rossi, MD Associate Chair, Division of Hepatology Einstein Medical Center Philadelphia Consultant for BMS Speaker for Gilead Disclosures I have no conflicts to report
More informationHepatitis A and Hepatitis E
Hepatitis A and Hepatitis E Luis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology & Nutrition University of Louisville and Louisville VAMC 2011 Viruses that cause Hepatitis
More informationHepatitis E in South Africa. Tongai Maponga
Hepatitis E in South Africa Tongai Maponga 7th FIDSSA CONGRESS 2017 This is what usually comes to mind History of hepatitis E virus An ET-NANB hepatitis virus later named HEV was first suspected in 1980.
More informationUses and Misuses of Viral Hepatitis Testing. Origins of Liver Science
Uses and Misuses of Viral Hepatitis Testing Richard S Lang, MD, MPH, FACP Chairman, Preventive Medicine Vice-Chair, Wellness Institute Raul J Seballos, MD, FACP Vice-Chair, Preventive Medicine Wellness
More informationViral Hepatitis in Reproductive Health
Viral Hepatitis in Reproductive Health Training Course in Sexual and Reproductive Health Research Geneva 2010 Dr José M Bengoa Dr Pierre Jean Malè Consultants Division of Gastroenterology and Hepatology
More informationJMSCR Volume 03 Issue 03 Page March 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-237-17x Seroprevalence of Hepatitis A and E Virus IgM in Children Suffering from Acute Hepatitis Authors Sumit Kumar Rawat 1, Dr Ashish Jain 2 1
More informationViral hepatitis Blood Born hepatitis. Dr. MONA BADR Assistant Professor College of Medicine & KKUH
Viral hepatitis Blood Born hepatitis Dr. MONA BADR Assistant Professor College of Medicine & KKUH Outline Introduction to hepatitis Characteristics of viral hepatitis Mode of transmission Markers of hepatitis
More informationLearning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses.
Learning Objectives: Hepatitis Update ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Upon attendance of this seminar and review of material provided, the attendees will be able to: 1. List hepatitis viruses
More informationConfirmed (Laboratory Tests) Serum positive for IgM anti-hbc or, hepatitis B surface antigen (HbsAg).
Hepatitis B Hepatitis B is a liver disease that results from infection with the Hepatitis B virus. It can range in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis
More informationEpidemiology of hepatitis E infection in Hong Kong
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Epidemiology of hepatitis E infection in Hong Kong DPC Chan *, KCK Lee, SS Lee K e y M e s s a g e s 1. The overall anti hepatitis E virus (HEV) seropositivity
More informationHEV Infection as an Aetiologic Factor for Acute Hepatitis: Experience from a Tertiary Hospital in Bangladesh
J HEALTH POPUL NUTR 2009 Feb;27(1):14-19 ISSN 1606-0997 $ 5.00+0.20 INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH, BANGLADESH HEV Infection as an Aetiologic Factor for Acute Hepatitis: Experience
More informationEpidemiology Update Hepatitis A
December 2011 Epidemiology Update Hepatitis A Hepatitis A Key Points Between 2000 and 2010, 209 cases of hepatitis A were reported in Hennepin County residents. This represents 30% of the cases reported
More informationMedia centre. WHO Hepatitis B. Key facts. 1 of :12 AM.
1 of 5 2013-08-02 7:12 AM Media centre Hepatitis B Share Print Fact sheet N 204 Updated July 2013 Key facts Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic
More informationEpidemiological profiles of viral hepatitis in Italy Effects of migration
Epidemiological profiles of viral hepatitis in Italy Effects of migration Hepatitis A and E T. Santantonio UOC di Malattie Infettive Università degli Studi di Foggia Azienda Ospedaliero-Universitaria Ospedali
More informationChapter 2 Hepatitis B Overview
Chapter 2 Hepatitis B Overview 23 24 This page intentionally left blank. HEPATITIS B OVERVIEW Hepatitis B Virus The hepatitis B virus (HBV) belongs to the Hepadnaviridae family and is known to cause both
More informationHepatitis E in humans. Alfredo Pérez (Hospital 12 de Octubre, Madrid. Spain)
Hepatitis E in humans Alfredo Pérez (Hospital 12 de Octubre, Madrid. Spain) VIRAL HEPATITIS Those caused by different viruses with primary tropism for the liver tissue History (discovery) Hepatitis A Hepatitis
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationViral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a
Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes
More informationHepatitis A Case Investigation and Outbreak Response. Terrie Whitfield LPN Public Health Representative
Hepatitis A Case Investigation and Outbreak Response Terrie Whitfield LPN Public Health Representative Training Objectives Provide an overview of HAV epidemiology Present reporting criteria and HAV case
More informationHepatitis A Hepatitis D Hepatitis E HSV CMV EBV
Ammar Hassan PGY-4 Hepatotropic Viruses Nominal Viruses Hepatitis A Hepatitis D Hepatitis E HSV CMV EBV HEPATITIS A *Non-enveloped, single-stranded RNA virus. *Only one known serotype. *The primary route
More informationEpidemiology of hepatitis E: Current status
doi:10.1111/j.1440-1746.2009.05933.x EPIDEMIOLOGY MINISERIES jgh_5933 1484..1493 Epidemiology of hepatitis E: Current status Rakesh Aggarwal and Sita Naik Departments of Gastroenterology and Immunology,
More informationChronic Hepatitis C. Risk Factors
Chronic Hepatitis C The hepatitis C virus is one of the most important causes of chronic liver disease in the United States. Almost 4 million Americans or 1.8 percent of the U.S. population have an antibody
More informationHepatitis and pregnancy
Hepatitis and pregnancy Pierre-Jean Malè MD Training Course in Reproductive Health Research WHO Geneva 2008 26.02.2008 Liver disease and pregnancy: three possible etiologic relationship the patient has
More informationEnd Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC
End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP-BC Introduction (https://www.srtr.org) What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC
More informationEnd Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC
End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC Introduction (https://www.srtr.org) 1 What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC
More informationLESSON ASSIGNMENT. After completing this lesson, you should be able to: 7-1. Identify the common types of hepatitis.
LESSON ASSIGNMENT LESSON 7 Hepatitis. LESSON ASSIGNMENT Paragraphs 7-1 through 7-11. LESSON OBJECTIVES After completing this lesson, you should be able to: 7-1. Identify the common types of hepatitis.
More informationViral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital
Viral Hepatitis Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis HAV HBV HCV HDV HEV Other viral: CMV, EBV, HSV Unknown Hepatitis A Hepatitis A Transmitted via the faecal-oral route
More informationAcute hepatitis can be a severe disease among. Acute Hepatitis in Israeli Travelers ORIGINAL ARTICLE
I S T M 232 ORIGINAL ARTICLE Acute Hepatitis in Israeli Travelers Tamar Lachish, MD, Moshik Tandlich, DMD, and Eli Schwartz, MD, DTMH The Infectious Diseases Unit, Shaare-Zedek Medical Center, Jerusalem,
More informationIs it the time to start blood screening for Hepatitis-E?
Is it the time to start blood screening for Hepatitis-E? Dr. Somnath Mukherjee MD, MAMS Assistant Professor All India Institute of Medical Sciences Bhubaneswar During last 25 years the safety of blood
More informationHepatitis A Virus: Old Things Made New
Hepatitis A Virus: Old Things Made New Cody A. Chastain, MD Assistant Professor of Medicine Viral Hepatitis Program Division of Infectious Diseases Vanderbilt University Medical Center Cody.A.Chastain@VUMC.org
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
PAGE 1 of 5 PURPOSE To provide guidelines on the treatment and care of patients with Hepatitis. POLICY Hepatitis is an injury to hepatic cells and an inflammatory process in the liver. The major causes
More informationHepatitis C Best Practice Guidelines For Local Health Departments
Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have
More information2/7/2013. The ABC s (and D & E s) of the Viral Hepatitides Part 1 INTRODUCTION
The ABC s (and D & E s) of the Viral Hepatitides Part 1 Thomas Novicki PhD DABMM Clinical Microbiologist Division of Laboratory Medicine novicki.thomas@marshfieldclinic.org Objectives 2 1. Explain the
More informationRama Nada. - Malik
- 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect
More informationLifetime risk of infection >60% Early childhood infections common
Hepatitis Community Medicine HBV Public health sig HBV is 100 times more infectious than HIV. >350 million chronically infected worldwide. >1 million people die annually of HBV- related chronic liver disease.
More informationWe need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles
0 We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles in diagnosing patients but also after diagnosis, helping
More informationHepatitis A-E Viruses. Dr Nemes Zsuzsanna
Hepatitis A-E Viruses Dr Nemes Zsuzsanna Viral Hepatitis - Historical Perspectives Infectious A E Enterically transmitted Viral hepatitis NANB Serum B D C Parenterally transmitted HGV, TTV, SEN, other
More informationAn Outbreak Investigation of Jaundice Cases in Vadodara District
ORIGINAL ARTICLE pissn 0976 3325 eissn 2229 6816 Open Access Article www.njcmindia.org An Outbreak Investigation of Jaundice Cases in Vadodara District Alpesh S Patel 1, Pankaj P Taviad 2, Raman D Damor
More informationCOURSE DESCRIPTION. Copyright Information
COURSE DESCRIPTION This continuing education course will review six types of hepatitis: Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis E, and Hepatitis G. Information about symptoms, diagnosis,
More informationViral Hepatitis - Historical Perspective
Viral Hepatitis - Historical Perspective Infectious A E Enterically transmitted Viral hepatitis NANB Serum B D F, G,? other C Parenterally transmitted Before the discovery of hepatitis A virus (HAV) and
More informationHepatitis B. Data from the Travel Health Surveillance Section of the Health Protection Agency Communicable Disease Surveillance Centre
Hepatitis B Introduction Hepatitis B virus is one of the most prevalent viruses worldwide and is a major cause of chronic liver disease and hepatocellular carcinoma. It is a hepadnavirus, consisting of
More informationNotes Setting the Scene
We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles in diagnosing patients but also after diagnosis, helping
More informationHepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E.
What is Hepatitis? Hepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E. Hepatitis A and E are not chronic and are mostly present in areas
More informationHEPATITIS VIRUSES. Other causes (not exclusively hepatitis v.)also called sporadic hepatitis: HEPATITIS A(infectious hepatitis)
Dept.of Microbiology/Virology Assist.prof. Shatha F. Abdullah HEPATITIS VIRUSES Medically important hepatitis v. (liver)are: 1.HAV 2.HBV 3.HCV 4.HDV 5.HEV 6.HGV Other causes (not exclusively hepatitis
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091650 Age 49 Years Gender Male 29/8/2017 120000AM 29/8/2017 100248AM 29/8/2017 105306AM Ref By Final HEATITIS, VIRAL, COMREHENSIVE ANEL HEATITIS A ANTIBODY (ANTI
More informationUpdate of hepa++s E in Hong Kong. Dr Chow Chi Wing Department of Medicine Tseung Kwan O Hospital
Update of hepa++s E in Hong Kong Dr Chow Chi Wing Department of Medicine Tseung Kwan O Hospital HEV: The History Probably causing human disease for centuries Iden+fied on EM by Dr Balayan in 1983 Viral
More informationViral Hepatitis. Dr. Abdulwahhab S. Abdullah CABM, FICMS-G&H PROF. DR. SABEHA ALBAYATI CABM,FRCP
Viral Hepatitis Dr. Abdulwahhab S. Abdullah CABM, FICMS-G&H PROF. DR. SABEHA ALBAYATI CABM,FRCP Viral hepatitis Viral hepatitis must be considered in any patient presenting with hepatitis on LFTs (high
More informationNew recommendations for immunocompromised patients
New recommendations for immunocompromised patients Hepatitis E Virus (HEV): Transmission, incidence and presentation Emerging evidence regarding HEV transmission from blood components and dietary consumption
More informationModule 1 Introduction of hepatitis
Module 1 Introduction of hepatitis 1 Training Objectives At the end of the module, trainees will be able to ; Demonstrate improved knowledge of the global epidemiology of the viral hepatitis Understand
More informationEPIDEMIOLOGY OF HEPATITIS A IN IRELAND
EPIDEMIOLOGY OF HEPATITIS A IN IRELAND Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results 8 Discussion 10 References 11 Epidemiology of Hepatitis
More informationWorld Health Organization. Western Pacific Region
Basic modules for hepatitis 1 Basic Module 1 Liver anatomy and physiology 2 Position of liver Midline Located in right upper abdomen Protected by the right rib cage Right upper Measures: 12 15 cm in vertical
More informationViral Hepatitis in Children DR. HOSSAIN IBRAHIM AGEEL PEDIATRIC GASTROENTEROLOGIST PEDIATRIC DEPARTMENT KFCH JAZAN
Viral Hepatitis in Children DR. HOSSAIN IBRAHIM AGEEL PEDIATRIC GASTROENTEROLOGIST PEDIATRIC DEPARTMENT KFCH JAZAN General Concepts Hepatitis = 'inflammation of the liver'. Virus causes: Hepatotropic and
More informationSojan George Kunnathuparambil, Kattoor Ramakrishnan Vinayakumar, Mahesh R. Varma, Rony Thomas, Premaletha Narayanan, Srijaya Sreesh
Original article Annals of Gastroenterology (2013) 26, 1-5 Bilirubin, aspartate aminotransferase and platelet count score: a novel score for differentiating patients with chronic hepatitis B with acute
More informationResearch article Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data
Acute Hepatitis E Infection In A Visitor To Louisiana.(Case Report): An Article From: Southern Medical Journal [HTML] [Digital] By James Edward, Jr. Walker;Todd Martin Brown;Thomas Lanier Hagood;William
More informationHepatitis A Surveillance Protocol
Provider Responsibilities 1. Report all cases to your local health department within the timeframe indicated: Sporadic case of - should be reported within 24 hours of diagnosis. Outbreaks of - should be
More informationSummary of Key Points WHO Position Paper on Vaccines against Hepatitis E Virus(HEV) May 2015
Summary of Key Points WHO Position Paper on Vaccines against Hepatitis E Virus(HEV) May 2015 1 Background l Hepatitis E Virus (HEV): leading cause of acute viral hepatitis in developing countries. l Genotypes
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091606 Age 24 Years Gender Male 30/8/2017 92800AM 30/8/2017 94631AM 31/8/2017 90306AM Ref By Final HEATITIS A & B VIRUS EVALUATION HEATITIS A ANTIBODY (ANTI HAV),
More informationGiardiasis. Table of Contents
Table of Contents Case Definition... Error! Bookmark not defined. Reporting Requirements... 2 Etiology... Error! Bookmark not defined. Clinical Presentation... Error! Bookmark not defined. Diagnosis...
More informationHepatitis E Vaccine Clinical Experience. Mrigendra P. Shrestha
Hepatitis E Vaccine Clinical Experience Mrigendra P. Shrestha 1 Hepatitis E in Nepal 2 Hepatitis E in Nepal Most common type of acute viral hepatitis Occurs in annual rainy season outbreaks Responsible
More informationIN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST
IN THE NAME OF GOD AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL D r. MANIJE DEZFULI INFECTIOUS DISEASES SPECIALIST Acute Viral Hepatitis The Anatomy of the Liver Hepatic Physiology Liver: Largest solid organ
More informationDiagnosis of Acute HCV Infection
Hepatitis C Online PDF created December 20, 2017, 7:54 pm Diagnosis of Acute HCV Infection This is a PDF version of the following document: Module 1: Screening and Diagnosis of Hepatitis C Infection Lesson
More informationClinical course and duration of viremia in vertically transmitted hepatitis E virus infection in babies born to HEV-infected mothers
Journal of Viral Hepatitis, 00 doi:./j.-.00.0.x 0 Clinical course and duration of viremia in vertically transmitted hepatitis E virus infection in babies bn to HEV-infected mothers M. S. Khuroo, S. Kamili
More informationLiver and pregnancy part 2 : pregnancy in patient with underlying liver disease
Liver and pregnancy part 2 : pregnancy in patient with underlying liver disease Ahmad Shavakhi.MD Associate professor Isfahan university of medical sciences Pregnancy in cirrhosis Pregnancy is a rare event
More informationkeyword: hepatitis Hepatitis
www.bpac.org.nz keyword: hepatitis Hepatitis Key reviewers: Dr Susan Taylor, Microbiologist, Diagnostic Medlab, Auckland Dr Tim Blackmore, Infectious Diseases Physician and Microbiologist, Wellington Hospital,
More informationBiology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s)
Biology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s) STI s once called venereal diseases More than 20 STIs have now been identified most prevalent among teenagers and young adults.
More informationViral Hepatitis. Author: Nicolene Naidu
Viral Hepatitis Author: Nicolene Naidu Bachelor of Biological Science (Cellular Biology), Bachelor of Medical Science (Medical Microbiology) (Honours) The liver is the largest gland in the human body and
More informationHEPATITIS A. Figure 35. Figure 36. Hepatitis A Incidence Rates by Year LAC and US,
HEPATITIS A CRUDE DATA Number of Cases 839 Annual Incidence a LA County 9.1 California 9. United States 4.9 Age at Onset Mean 27 Median 22 Range months - 97 years Case Fatality LA County.% United States
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
8 April 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH PROGRAMME SUBCOMMITTEE Sixty-fourth session Brazzaville, Republic of Congo, 9 11 June 2014 Provisional agenda item 6 VIRAL HEPATITIS: SITUATION
More informationFulminant Hepatic Failure: Clinical Spectrum & Outcome
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 5 Ver. XII (May. 2017), PP 63-67 www.iosrjournals.org Fulminant Hepatic Failure: Clinical Spectrum
More informationVIRUS HEPATITIS IN PREGNANCY. Yvonne Cossart. Viruses in May- 2009
VIRUS HEPATITIS IN PREGNANCY Yvonne Cossart Viruses in May- 2009 Series of situations with potential problems for mother and baby acute infection during pregnancy persistent infection during pregnancy
More informationVIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...
5 November 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fourth session Cotonou, Republic of Benin, 3 7 November 2014 Provisional agenda item 11 VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES
More informationEpatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici. Ivana Maida
Epatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici Ivana Maida Positivity for HBsAg was found in 0.5% of tested women In the 70s and 80s, Italy was one of the European countries
More informationHepatitis B infection
Hepatitis B infection Kenneth Kabagambe Executive Director The National Organization for People Living with Hepatitis B (NOPLHB Uganda General introduction: Viral hepatitis in Uganda Viruses that affect
More informationHepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:
Hepatitis Dr. Mohamed. A. Mahdi Mob: 0123002800 5/2/2019 Hepatitis Hepatitis means the inflammation of the liver. May cause by viruses or bacteria, parasites, radiation, drugs, chemical and toxins (alcohol).
More informationHEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38
2016 Annual Morbidity Report HEPATITIS C, ACUTE a Rates calculated based on less than 19 cases or events are considered unreliable b Calculated from: CDC. Notice to Readers: Final 2016 Reports of Nationally
More informationCommonly Asked Questions About Chronic Hepatitis C
Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral
More informationViral Hepatitis in the WHO South-East Asia Region
SEA-CD-232 Distribution: General Viral Hepatitis in the WHO South-East Asia Region Know it. Confront it. Hepatitis affects everyone, everywhere. World Health Organization 2011 All rights reserved. Requests
More informationE E Hepatitis E SARS 29, Lancet. E A B Enterically-Transmitted Non-A, Hepatitis E. Virus HEV nm. 1.35g/cm s ALT AST HEV HEV
7850 2004 Hepatitis E Tian-Cheng LI Naokazu TAKEDA Tatsuo MIYAMURA SARS 8 Lancet E E E Hepatitis E VirusHEV E E HEV HEV E 1955 29,000 E E A A B Enterically-Transmitted Non-A, Non-B Hepatitis 1983 Balayan
More informationHepadnaviridae family (DNA) Numerous antigenic components Humans are only known host May retain infectivity for more than 7 days at room temperature
Hepatitis B Epidemic jaundice described by Hippocrates in 5th century BC Jaundice reported among recipients of human serum and yellow fever vaccines in 1930s and 1940s Australia antigen described in 1965
More informationHepatitis B (Part 1 - intro)
Hepatitis B (Part 1 - intro) The Hepatitis B virus (HBV) l Virology Discovered in 1966 double-stranded DNA virus l family of hepadnaviruses l HBV unique to Humans (Primates too in laboratory studies) no
More informationHepatitis C Virus (HCV)
Clinical Practice Guidelines Hepatitis C Virus (HCV) OBJECTIVE The purpose is to guide the appropriate diagnosis and management of Hepatitis C Virus (HCV). GUIDELINE These are only guidelines, and are
More informationHepatitis A Virus Infections
Hepatitis A Virus Infections Robert L. Brawley, MD, MPH, FSHEA Chief, Infectious Disease Branch Division of Epidemiology and Health Planning Kentucky Department for Public Health Objectives Discuss the
More informationOverview of Hepatitis C Virus: The Challenge & The Opportunity. Cody A. Chastain, MD
Overview of Hepatitis C Virus: The Challenge & The Opportunity Cody A. Chastain, MD Disclosures Research supported by Gilead Sciences Inc.: Site investigator for HIV/HCV SWITCH Registry Study Key faculty
More informationObjectives. Acute Hepatitis: Symptoms. Acute Hepatitis: Signs HIHIM 409. Acute Viral Hepatitis by Type, United States,
Objectives Viral Hepatitis: ABCD&E HIHIM 409 Describe the Clinical Syndromes of Viral Hepatitis List the modes of Transmission Understand and be able to interpret Diagnostic (laboratory) tests Know the
More informationSome HCV History 1970s: many cases reported called non-a, non-b hepatitis
Hepatitis C virus 1 Some HCV History 1970s: many cases reported called non-a, non-b hepatitis 1988: hepatitis C virus identified 1990: antibody screening tests available 1992: better tests to insure safety
More informationWest Nile Fever. F. Karup Pedersen 2012
F. Karup Pedersen 2012 West Nile virus first isolated 1937 in West Nile district, Uganda Japanese encephalitis reconvalescens serum could neutralize West Nile virus Virus antigenically related to Japanese
More informationHealth, Seniors and Active Living
Health, Seniors and Active Living Public Health and Primary Health Care 4 th Floor 300 Carlton, Winnipeg MB R3B 3M9 T 204-788-6737 F 204-948-2190 Website: www.gov.mb.ca/health/ August 2017 Re: Hepatitis
More informationManagement of Hepatitis B - Information for primary care providers
Management of Hepatitis B - Information for primary care providers July 2018 Chronic hepatitis B (CHB) is often a lifelong condition. Not everyone infected needs anti-viral therapy. This document outlines
More informationWhat s Lurking out there??????
What s Lurking out there?????? Dave Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene david.warshauer@slh.wisc.edu WISCONSIN STATE LABORATORY OF HYGIENE
More informationTest Name Results Units Bio. Ref. Interval
LL - LL-ROHINI (NATIONAL REFERENCE 135091608 Age 26 Years Gender Female 30/8/2017 92900AM 30/8/2017 94717AM 31/8/2017 90216AM Ref By Final HEATITIS ACUTE VIRUS CONFIRMATION HEATITIS A ANTIBODY (ANTI HAV),
More informationHBV : Structure. HBx protein Transcription activator
Hepatitis B Virus 1 Hepatitis B Virus 2 Properties of HBV a member of the hepadnavirus group Enveloped, partially double-stranded DNA viruses, smallest DNA virus Replication involves a reverse transcriptase
More informationKhaled Ali Abu Ali. BSN. MPH. Ph.D. cand. -Nursing. Director of Epidemiology Department UCAS Lecturer
Khaled Ali Abu Ali BSN. MPH. Ph.D. cand. Director of Epidemiology Department UCAS Lecturer -Nursing Khaled_abuali@yahoo.com Communicable Disease Surveillance during Gaza War, 214. Introduction Public Health
More informationYellow fever. Key facts
From: http://www.who.int/en/news-room/fact-sheets/detail/yellow-fever WHO/E. Soteras Jalil Yellow fever 14 March 2018 Key facts Yellow fever is an acute viral haemorrhagic disease transmitted by infected
More informationDiscovery of hepatitis A virus (HAV) and hepatitis
REVIEW Hepatitis E Rakesh Aggarwal 1 and Shahid Jameel 2 Hepatitis E refers to liver disease caused by the hepatitis E virus (HEV), a small, nonenveloped virus with a single-stranded RNA genome. The virus
More information